End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
178,700 KRW | +3.35% | +0.06% | -11.32% |
Apr. 17 | Celltrion, Inc. announces an Equity Buyback for 436,047 shares. | CI |
Apr. 17 | Celltrion, Inc. authorizes a Buyback Plan. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.32% | 26.87B | |
-0.02% | 42.11B | |
+48.66% | 40.08B | |
+5.04% | 40B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B | |
-18.61% | 9.87B |
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Celltrion Submits Stage Three Clinical Trial Approval Request for Multiple Sclerosis Drug Biosimilar to US FDA